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CASE REPORT
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY (GUILLAIN-BARRÉ 
SYNDROME) FOLLOWING DENGUE FEVER
Eduardo GONÇALVES
SUMMARY
This paper reports a case of dengue in a six-year-old female child who suddenly developed excruciating headaches, fever, myalgia 
and paresis. Laboratory examinations included blood count, platelet count, biochemical tests (BUN, creatinine, aminotransferases, 
and total bilirubin and bilirubin fractions) and specific IgM titers (enzyme-immunoassay with recombinant tetravalent dengue). 
After ten days of hospitalization and having already been in a home environment, a new clinical image emerged, characterized by 
dysphagia, dysphonia, weakness, peripheral facial palsy and paresthesia. The diagnosis of Guillain-Barré Syndrome was based on 
clinical findings, cerebrospinal fluid examination, electrophysiological findings and the exclusion of other pathologies. Our case, as 
some shown in previous reports, calls attention to the possibility that Guillain-Barré Syndrome may occur in association with dengue.
KEYWORDS: Acute inflammatory demyelinating polyradiculoneuropathy; Dengue fever; Guillain-Barré Syndrome; Neurological 
dengue.
INTRODUCTION
Dengue is an acute febrile infectious disease caused by arboviruses, 
which belongs to the Flaviviridae family and are transmitted by two 
species of mosquitoes, the Aedes aegypti (which is the most common) 
and the A. albopictus4,7. To date, four serotypes are known: (DEN-1, 
DEN-2, DEN-3 and DEN-4)7. According to estimates by the World 
Health Organization, about 80 million people become infected annually 
and between 2.5 and three billion people are at risk of infection in 100 
countries in all continents, except Europe4,7.
Guillain-Barré Syndrome (GBS) is an acute inflammatory 
demyelinating polyneuroradiculopathy that often develops after infection, 
mainly viral infection. Cytomegalovirus, Epstein-Barr Virus and HIV 
are some of the viral agents associated with this neurological syndrome. 
Some studies call attention to the possible association between dengue 
and GBS8.
We report a case of a six-year-old female who developed GBS 20 
days after the onset of dengue symptoms. This report was approved 
by the Institutional Ethics Committee and the patient’s legal guardian 
signed a free and clear consent form written in terminology that is easy 
to understand. 
CASE REPORT
ARN, female, six-year-old child was seen on January 2, 2011 at 
University Hospital with an excruciating headache, osteomioarticular 
pain, muscle weakness and fever. She was diagnosed with dengue 
fever 24 hours later and was hospitalized for ten days. The diagnosis 
was confirmed after clinical research examinations, which included 
blood count, platelet count, biochemical tests (BUN, creatinine, 
aminotransferases, and total bilirubin and bilirubin fractions) and by 
specific IgM titers (enzyme-immunoassay with recombinant tetravalent 
dengue) (Table 1).
On January 22, 2011, ten days after discharge, the patient began 
presenting dysphagia, dysphonia, vomiting and ascending paresthesia 
(predominantly in the distal third of the limbs). She was referred to 
the Pediatric Intensive Care Unit (PICU) with what appeared to be 
tetraparesis, peripheral facial paralysis of the right side, paralysis of 
eye movements and anarthria. Six days later the patient was diagnosed 
with GBS, based on cerebrospinal fluid examination (analysis showed 
lymphocytic pleocytosis with a normal glucose value and negative 
bacterial and fungal cultures) (Table 2), electrophysiological findings 
and the exclusion of other pathologies. Electrophysiology in this 
patient disclosed an abnormal demyelination pattern. She remained 
hospitalized for 20 days with medication (intravenous immunoglobulin 
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400 mg/kg/day per five days) and ventilatory support as well as 
rehabilitation. She returned to daily activities and recovered her gait 
patterns after two months of rehabilitation. 
At the neurological examination held on May 10, 2011, residual 
sequelae were found. The physical examination showed tetraparesis 
and sensory disorders (tactile hypoesthesia, temperature and pain in the 
distal third of the limbs, and hypopallesthestia). The patient recovered 
completely from the neurologic impairment caused by the involvement 
of the nuclei of the cranial nerves, except for the pitch and intensity 
of her voice (dysphonia). The gait patterns were unchanged; however, 
the speed as well as the timing of the ascent and descent of stairs was 
affected. With exception to the patellar reflex (bilateral hyporeflexia), 
the remaining deep reflexes also appear unaffected. Because the patient 
reports instability and insecurity while walking, she was directed to 
continue with rehabilitation.
DISCUSSION
Dengue is the most common human arboviral infection and has 
been recognized as a clinical entity since 17806. During the nineteenth 
century, dengue was considered a sporadic disease, causing epidemics at 
long intervals. However, dramatic changes in this pattern occurred and 
currently dengue is considered the most common viral disease transmitted 
by mosquitoes across the globe, being endemic in 112 countries. In 
tropical countries, annual outbreaks have occurred since 19863. 
In most cases, the disease has a self-limited course, with nonspecific 
symptoms such as fever, feeling ill and weakness. The most striking 
characteristics include intense muscle pain and retro-ocular headache, 
which may or may not be associated with a cutaneous rash8. 
Many neurological symptoms are associated with dengue and have 
been recognized for over a century. The classic signs of acute infection are 
headache, dizziness, lightheadedness, insomnia, agitation, irritability and 
depression. A minority of symptoms manifests as encephalopathy. The 
post-infectious sequelae are mainly amnesia, dementia, manic psychosis, 
Reye’s syndrome and meningoencephalitis3. However, most cases do 
not describe demyelination as a specific complication. Laboratory tests 
show elevated liver enzymes, leukopenia and thrombocytopenia, but 
these changes are not specific to dengue1.
Despite frequent and severe dengue epidemics, there have been few 
reported cases involving neurological complications associated with the 
infection of this virus. This fact can be explained because, unlike other 
arboviruses2, this virus rarely affects the central nervous system. The 
pathophysiology of these neurological complications can be explained 
by the occurrence of cerebral edema, cerebral hemorrhage, hyponatremia, 
liver failure associated with portasystemic encephalopathy, cerebral 
anoxia, microcapillary hemorrhage and/or the release of toxic products, 
which can occur separately or together9. Among the neurological 
manifestations that appear post-dengue, which may occur after the dengue 
fever and the following hemorrhagic dengue, post-infectious encephalitis, 
meningoencephalomyelitis, transverse myelitis, epilepsy, tremors, Bell’s 
palsy, mononeuropathies and GBS stand out5.
GBS occurs at an incidence of between 0.6 and 1.9 per 100,000 
inhabitants and is characterized by ascending flaccid paralysis, deep 
areflexia and sensory changes. The examination of the cerebrospinal 
fluid reveals an albumin-cytologic dissociation.
Some previous reports, as with our case, call attention to the 
possibility that GBS may occur in association with dengue3, although the 
mechanisms that relate to this infection are not known. However, there is 
evidence that this is an immune-mediated neurological disease9. The same 
pro-inflammatory substances that participate in the immune response to 
the dengue virus (tumor necrosis factor-α, complement, interleukins) also 
have an important role in the pathogenesis of GBS, which can establish 
the relationship between the two conditions5. In all previous reports, the 
onset of GBS occurred after the recovery of the initial infection. This 
fact was also observed in the patient in question.
The first report of post-dengue infection GBS in children is referred 
in the study of SULEKHA et al.10. The authors describe three children, 
all under the age of eight, who suddenly experienced ascending motor 
paralysis, sensory disturbances and albumin-cytological dissociation in 
the CSF after being infected by dengue some days before. 
In 2004 CUNHA-MATTA et al.1 reported the case of a 14-year-old 
Table 1
Lab tests in a case of Guillain-Barré syndrome following dengue fever in a 
six-year-old child
Lab test Jan, 2 Jan, 22 Feb, 10
Hemogram
Erythrocytes (x106/mm3) 4.3 4.1 4.3
Hemoglobin (g/dL) 12.5 12.0 12.5
Hematocrit (%) 38 36.0 38.0
RDW (%) 12.5 13.0 13.5
Leukocytes (/mm3) 3100 3000 7000
Platelets (/mm3) 130000 90000 140000
Urea (mg/dL) 35 35 40
Creatinine (mg/dL) 1.1 1.2 0.9
Total Bilirubin (mg/dL) 1.6 1.9 1.1
AST (U/L) 70 65 35
ALT (U/L) 80 80 40
Serology for dengue IgM 2.7 IgM 3.3
 IgG < 0.9 IgG 5.4
RDW - Red Cell Distribution Width; AST - Aspartato Aminotransferase; ALT - 
Alanina Aminotransferase.
Table 2
Cerebrospinal fluid (CSF) in a case of Guillain-Barré Syndrome following 
dengue fever in a six-year-old child
Lab test January, 22 February, 10
Glucose (mg/dL) 45 40
Protein (mg/dL) 120 360
WBCs (cells/µL) 80 60
Cell differential 75% lymphocytes 85% lymphocytes
Culture Negative Negative
WBC - White Blood Cells.
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patient with what appeared to be ascending flaccid, areflexic tetraparesis, 
with electrophysiological findings consistent with GBS, beginning ten 
days after the classical form of dengue appeared. There was a complete 
functional recuperation, leaving only a deep areflexia. This recovery also 
occurred in our patient who, after recovery, was able to walk without 
support for independent daily living activities, although there were some 
residual sequelae.
CONCLUSION
Our case calls for special attention because the dengue infection 
remains a serious public health problem in many countries and yet little 
is known about the actual incidence of neurological complications caused 
by the infection of the dengue virus. Therefore, it is important to consider 
dengue as a possible cause of GBS. 
RESUMO
Polirradiculoneuropatia desmielinizante inflamatória aguda 
(síndrome de Guillain-Barré) após dengue
Este trabalho relata o caso de uma criança, sexo feminino, seis anos 
que desenvolveu subitamente cefaléia lancinante, febre, mialgia e paresia. 
Os exames de investigação clínica, que incluíram hemograma, contagem 
de plaquetas, dosagens bioquímicas (uréia, creatinina, transferases e 
billirrubina total e frações) e por títulos específicos de IgM, por enzima-
imunoensaio (EIA) com antígeno tetravalente de dengue. Após dez dias 
de internação e já em ambiente domiciliar, novo quadro clínico surgiu 
caracterizado por disfagia, disfonia, paresia, paralisia facial periférica e 
parestesias. O diagnóstico do dengue e da Síndrome de Guillain-Barré 
foi baseado nos achados clínicos, no exame do líquido cefalorraquidiano, 
achados eletrofisiológicos e na exclusão de outras patologias. Neste caso, 
como em alguns relato anteriores, chama a atenção para a possibilidade 
de que Síndrome de Guillain-Barré pode ocorrer em associação com a 
dengue.
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